LEXINGTON, Mass.--(BUSINESS WIRE)--Synta Pharmaceuticals Corp. (NASDAQ: SNTA), a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that the Company will be presenting at the Rodman & Renshaw 10th Annual Global Healthcare Conference on Monday, November 10 at 2:50 p.m. (ET) at the New York Palace Hotel.
